Metraipolis › archive › dc_ad42e7752f93

Post-marketing safety evaluation of mirogabalin using the JADER database — Europe PMC PMID:42328639

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42328639
DOI
10.3389/fphar.2026.1833433
License (as archived)
solo-consultazione
Archived
2026-10-31T19:09:54.417Z
SHA-256 of the archived text
c3d76e29e3794a0835c5ca1388880073df78004f7c005f56fcf76fc74cbe4f9d
Stable URL of this page
https://metraipolis.com/documento/dc_ad42e7752f93

How to cite

Post-marketing safety evaluation of mirogabalin using the JADER database — Europe PMC PMID:42328639 — Europe PMC (en), https://europepmc.org/article/MED/42328639 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad42e7752f93 (Metraipolis archive dc_ad42e7752f93, sha256 c3d76e29e3794a0835c5ca1388880073df78004f7c005f56fcf76fc74cbe4f9d)
BibTeX
@misc{dcad42e7752f93,
  title = {Post-marketing safety evaluation of mirogabalin using the JADER database — Europe PMC PMID:42328639},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42328639},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad42e7752f93; sha256 c3d76e29e3794a0835c5ca1388880073df78004f7c005f56fcf76fc74cbe4f9d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42328639. Agents can read the archived copy with the MCP tool read_document.